Literature DB >> 21922366

Long-term survival after resection of mass-forming type intrahepatic cholangiocarcinoma directly infiltrating the transverse colon and sequential brain metastasis: Report of a case.

Kenji Mimatsu1, Takatsugu Oida, Atsushi Kawasaki, Hisao Kano, Nobutada Fukino, Kazutoshi Kida, Youichi Kuboi, Sadao Amano.   

Abstract

MUC1 expression in cholangiocarcinoma is considered to be correlated with patient survival. We report a case of mass-forming type intrahepatic cholangiocarcinoma (ICC) with direct infiltration of the transverse colon and sequential brain metastasis. The patient was treated by curative right hepatectomy with right hemicolectomy followed by resection of the brain metastasis; there has been no evidence of recurrence in the 7 years since the hepatic resection. Thus, surgical resection may improve the prognosis of ICC involving the adjacent organs, even with brain metastasis. Immunohistochemical staining was performed for MUC1, MUC2, and MUC5AC. Although MUC1 expression was found in the liver tumor and metastatic brain tumor, the correlation between MUC1 expression and the prognosis of this patient was unclear. To clarify the correlation between immunohistochemical characteristics and prognosis, further studies on a greater number of cases of long-term survival of mass-forming type ICC are needed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922366     DOI: 10.1007/s00595-010-4500-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  17 in total

1.  Long-term survival after surgery for advanced intrahepatic cholangiocarcinoma: a case report.

Authors:  A M Hui; S Kawasaki; Y Hashikura; K Ishida; M K Miyazawa; M Makuuchi
Journal:  Hepatogastroenterology       Date:  1997 May-Jun

2.  MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients.

Authors:  S Yonezawa; K Sueyoshi; M Nomoto; H Kitamura; K Nagata; Y Arimura; S Tanaka; M A Hollingsworth; B Siddiki; Y S Kim; E Sato
Journal:  Hum Pathol       Date:  1997-03       Impact factor: 3.466

3.  MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.

Authors:  Chanchai Boonla; Banchob Sripa; Peti Thuwajit; Ubon Cha-On; Anucha Puapairoj; Masanao Miwa; Sopit Wongkham
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

4.  Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma.

Authors:  Naoki Matsumura; Masakazu Yamamoto; Atsushi Aruga; Ken Takasaki; Masayuki Nakano
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

5.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

6.  Cholangiocarcinoma presenting as a cerebellar metastasis: case report and review of the literature.

Authors:  M S Gudesblatt; W Sencer; M Sacher; C F Lanzieri; S K Song
Journal:  J Comput Tomogr       Date:  1984-07

Review 7.  Intrahepatic cholangiocarcinoma arising 34 years after excision of a type IV-A congenital choledochal cyst: report of a case.

Authors:  Kazuhiko Shimamura; Isao Kurosaki; Daisuke Sato; Kabuto Takano; Naoyuki Yokoyama; Yoshinobu Sato; Katsuyoshi Hatakeyama; Keiko Nakadaira; Minoru Yagi
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

8.  Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.

Authors:  Sin Young Park; Sang Jae Roh; Yo Na Kim; Sung Zoo Kim; Ho Sung Park; Kyu Yun Jang; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Woo Sung Moon
Journal:  Oncol Rep       Date:  2009-09       Impact factor: 3.906

9.  Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.

Authors:  Toshio Nakagohri; Taira Kinoshita; Masaru Konishi; Shinichiro Takahashi; Naoto Gotohda
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

10.  Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.

Authors:  Süleyman Yedibela; Resit Demir; Wei Zhang; Thomas Meyer; Werner Hohenberger; Frank Schönleben
Journal:  Ann Surg Oncol       Date:  2008-11-27       Impact factor: 5.344

View more
  5 in total

1.  Metastatic colon cancer from extrahepatic cholangiocarcinoma presenting as painless jaundice: case report and literature review.

Authors:  Benjamin W Vabi; Jeffrey Carter; Rong Rong; Minhua Wang; James G Corasanti; John F Gibbs
Journal:  J Gastrointest Oncol       Date:  2016-04

Review 2.  An update on liver surgery for cholangiocarcinoma.

Authors:  Karim Boudjema; Giovanni Battista Levi Sandri; Eveline Boucher; Tanguy Rohou; Michel Rayar; Laurent Sulpice
Journal:  Updates Surg       Date:  2013-10-02

3.  Colon Mass as a Secondary Metastasis from Cholangiocarcinoma: A Diagnostic and Therapeutic Dilemma.

Authors:  Azfar Niazi; Muhammad W Saif
Journal:  Cureus       Date:  2016-07-22

4.  Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review.

Authors:  Peiyi Xie; Lei Guo; Bo Zhang; Yongfeng Xu; Qi Song; Hongcheng Shi; Qinghai Ye; Hui Li; Yongsheng Xiao
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

5.  A Rare Clinical Presentation of Cholangiocarcinoma.

Authors:  Elisa Gravito-Soares; Marta Gravito-Soares; Pedro Figueiredo; Luis Tomé
Journal:  Case Rep Gastrointest Med       Date:  2017-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.